Starch-entrapped microsphere fibers improve bowel habit but do not exhibit prebiotic capacity in those with unsatisfactory bowel habits: a phase I, randomized, double-blind, controlled human trial.

Department of Clinical Nutrition, Rush University Medical Center, 1700 W VanBuren St Ste 425, Chicago, IL, USA 60612. Electronic address: Heather_Rasmussen@rush.edu. Department of Food Science, Purdue University, 745 Agriculture Mall Dr, West Lafayette, IN, USA 47907. Electronic address: hamakerb@purdue.edu. Rush Institute for Healthy Aging, Department of Internal Medicine, Rush University Medical Center, 1653 W Congress Pkwy, Chicago, IL, USA 60612. Electronic address: Kumar_Rajan@rush.edu. Division of Digestive Diseases and Nutrition, Department of Internal Medicine, Rush University Medical Center, 1725 W Harrison St Ste 206, Chicago, IL, USA, 60612. Electronic address: Ece_Mutlu@rush.edu. DNA Services Facility, Research Resources Center, 35 S Wolcott Ave STE E102, University of Illinois, Chicago, IL, USA 60612. Electronic address: greendna@uic.edu. Division of Digestive Diseases and Nutrition, Department of Internal Medicine, Rush University Medical Center, 1725 W Harrison St Ste 206, Chicago, IL, USA, 60612. Electronic address: Michael_Brown@rush.edu. Department of Food Science, Purdue University, 745 Agriculture Mall Dr, West Lafayette, IN, USA 47907. Electronic address: kaur1@purdue.edu. Division of Digestive Diseases and Nutrition, Department of Internal Medicine, Rush University Medical Center, 1725 W Harrison St Ste 206, Chicago, IL, USA, 60612. Electronic address: Ali_Keshavarzian@rush.edu.

Nutrition research (New York, N.Y.). 2017;:27-37

Abstract

Approximately one-third of individuals in the United States experience unsatisfactory bowel habits, and dietary intake, especially one low in fiber, could be partly responsible. We hypothesized that intake of a fermentable fiber (starch-entrapped microspheres, SM) that has a delayed, slow fermentation profile in vitro would improve bowel habit while exhibiting prebiotic capacity in those with self-described unsatisfactory bowel habits, all with minimal adverse effects. A total of 43 healthy volunteers completed a 3-month, double-blind, parallel-arm randomized clinical trial to assess the ability of a daily dose (9 or 12 g) of SM vs psyllium (12 g) to improve bowel habit, including stool consistency and frequency, and modify gut milieu through changes in stool microbiota and short-chain fatty acids while remaining tolerable through minimal gastrointestinal symptoms. All outcomes were compared before and after fiber treatment. Stool frequency significantly improved (P=.0003) in all groups after 3 months, but stool consistency improved only in both SM groups compared with psyllium. In addition, all groups self-reported a similar improvement in overall bowel habit with fiber intake. Both SM and psyllium resulted in minimal changes in microbiota composition and short-chain fatty acid concentrations. The present study suggests that supplementation with a delayed and slow-fermenting fiber in vitro may improve bowel habit in those with constipation, but further investigation is warranted to determine capacity to alter microbiota and fermentation profiles in humans. This trial was registered at ClinicalTrials.gov as NCT01210625.

Methodological quality

Metadata

MeSH terms : Dietary Fiber ; Prebiotics ; Starch